0001453687-24-000050.txt : 20240328
0001453687-24-000050.hdr.sgml : 20240328
20240328171138
ACCESSION NUMBER: 0001453687-24-000050
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240117
FILED AS OF DATE: 20240328
DATE AS OF CHANGE: 20240328
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SPRINGER TIMOTHY A
CENTRAL INDEX KEY: 0001055624
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37798
FILM NUMBER: 24800304
MAIL ADDRESS:
STREET 1: 36 WOODMAN ROAD
CITY: CHESTNUT HILL
STATE: MA
ZIP: 02467
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cartesian Therapeutics, Inc.
CENTRAL INDEX KEY: 0001453687
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 65 GROVE STREET
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: 617-923-1400
MAIL ADDRESS:
STREET 1: 65 GROVE STREET
CITY: WATERTOWN
STATE: MA
ZIP: 02472
FORMER COMPANY:
FORMER CONFORMED NAME: SELECTA BIOSCIENCES INC
DATE OF NAME CHANGE: 20090109
4
1
wk-form4_1711660282.xml
FORM 4
X0508
4
2024-01-17
0
0001453687
Cartesian Therapeutics, Inc.
RNAC
0001055624
SPRINGER TIMOTHY A
36 WOODMAN ROAD
CHESTNUT HILL
MA
02467
1
0
1
0
0
Common Stock
2024-01-17
4
P
0
800
0.69
A
87218
I
By wife
Common Stock
2024-02-06
4
P
0
800
0.65
A
88018
I
By wife
Common Stock
2024-02-07
4
P
0
2400
0.6563
A
90418
I
By wife
Common Stock
2024-03-08
4
P
0
4800
0.6639
A
95218
I
By wife
Common Stock
2024-03-11
4
P
0
1200
0.6541
A
96418
I
By wife
Common Stock
2024-03-12
4
P
0
1200
0.6122
A
97618
I
By wife
Common Stock
2024-03-13
4
P
0
3200
0.5837
A
100818
I
By wife
Common Stock
2024-03-14
4
P
0
2000
0.5305
A
102818
I
By wife
Common Stock
2024-03-15
4
P
0
1200
0.56
A
104018
I
By wife
Common Stock
2024-03-18
4
P
0
800
0.61
A
104818
I
By wife
Common Stock
7471625
D
Common Stock
33043849
I
See Footnote
The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $0.65 to $0.67. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $0.65 to $0.68. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $0.65 to $0.66. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $0.61 to $0.62. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $0.58 to $0.59. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $0.52 to $0.54. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Held by TAS Partners LLC. The reporting person is the managing member of TAS Partners LLC. The reporting person disclaims beneficial ownership of the securities held by TAS Partners LLC except to the extent of his pecuniary interest therein, if any.
/s/ Matthew Bartholomae, Attorney-in-Fact for Timothy A. Springer
2024-03-28